Aspire-Lakewood Holdings, Inc. (ASBP) vs Citius Pharmaceuticals, Inc. (CTXR)
- Aspire-Lakewood Holdings, Inc. ASBP 8.78 +1.62%
- Citius Pharmaceuticals, Inc. CTXR 0.46 0.00%
Aspire-Lakewood Holdings, Inc. and Citius Pharmaceuticals, Inc. are both Biotechnology companies. Aspire-Lakewood Holdings, Inc. and Citius Pharmaceuticals, Inc. are of similar size ($12.6M and $12.1M). Citius Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire-Lakewood Holdings, Inc. trades at 0.2×. Citius Pharmaceuticals, Inc. has the higher net margin (0.00% vs −11,309.3%) and the lower return on invested capital (−58.7% vs 0.00%). Across the 14 metrics below, Citius Pharmaceuticals, Inc. leads on 8 and Aspire-Lakewood Holdings, Inc. on 6.
Valuation
Profitability
| Metric | ASBP | CTXR | Biotechnology median |
|---|---|---|---|
| Gross margin | (24.97%) | 0.00% | 65.16% |
| Operating margin | (7,491.61%) | 0.00% | 0.00% |
| Net margin | (11,309.31%) | 0.00% | 0.00% |
| Free cash flow margin | (7,355.07%) | 0.00% | 0.00% |
| Return on equity | (1,032.15%) | (64.51%) | (56.36%) |
| Return on assets | (152.09%) | (34.29%) | (48.04%) |
| Return on invested capital | 0.00% | (58.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack